Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron vs Granisetron for CINV
NCT00359567Phase 3Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Jul 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Taiho Pharmaceutical Co., Ltd.. Started Jul 2006; status: completed.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00359567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00359567.